000 01767 a2200445 4500
005 20250517074350.0
264 0 _c20170110
008 201701s 0 0 eng d
022 _a1815-7920
024 7 _a10.5588/ijtld.15.0415
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZwerling, A
245 0 0 _aA simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens.
_h[electronic resource]
260 _bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
_cFeb 2016
300 _a257-60 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntitubercular Agents
_xadministration & dosage
650 0 4 _aComputer Simulation
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDecision Support Techniques
650 0 4 _aDisability Evaluation
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Costs
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHealth Services Accessibility
650 0 4 _aHumans
650 0 4 _aModels, Economic
650 0 4 _aMonte Carlo Method
650 0 4 _aPatient Selection
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
650 0 4 _aTuberculosis
_xdiagnosis
700 1 _aGomez, G B
700 1 _aPennington, J
700 1 _aCobelens, F
700 1 _aVassall, A
700 1 _aDowdy, D W
773 0 _tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
_gvol. 20
_gno. 2
_gp. 257-60
856 4 0 _uhttps://doi.org/10.5588/ijtld.15.0415
_zAvailable from publisher's website
999 _c25653229
_d25653229